June 20, 2025
R360 Longevity Circle co-chair Peter Fioretti talks about the rising interest in stem-cell therapies—and the importance of thoughtful exploration of emerging therapies.
In The San Francisco Standard’s new piece, “The New Luxury Medical Tourism Trend? $60K Stem-Cell Injections,” R360 Longevity Circle co-chair Peter Fioretti talks about the rising interest in stem-cell therapies—and the importance of thoughtful exploration of emerging therapies.
“We’re always discussing what has legitimacy and what’s snake oil,” he says. “And we have access to scientists and doctors researching it.”
At R360, medical innovation isn’t about chasing trends. That means asking informed questions, digging into the research, and learning directly from the scientists and clinicians shaping the field.
Disclosure: R360 is not an investment adviser. Information provided within is for educational purposes only and should not be construed, nor is intended to be, investment advice or a recommendation to invest in any types of securities. R360’s views are subject to change at any point without notice. No investment decision should be made based solely on the content herein and only a financial professional should be engaged for providing investment advice and recommendations. Past performance is not an indication of future returns.
